Cre8 EVO

Stents / DES – Cre8™EVO 

Cre8™ EVO is a highly innovative Drug Eluting Stent (DES) that is designed to face the clinical outcome challenges when treating patients undergoing PCI. Innovation is the only way to further improve current clinical patient outcome. That is what Cre8™ EVO is; a DES born from the most innovative technology to date.


The only polymer-free technology able to precisely control abluminal drug elution.

Fatty Acids enhance drug distribution and maximize drug bioavailability increasing device efficacy, particularly in diabetic patients.

New stent architecture designed for effective drug concentration, including complex coronary anatomies and pathologies like those of diabetic patients.

Proven hemo/biocompatibility versus lumen blood flow and faster strut coverage.

Coronary stent

  • Polymer-free device
  • Abluminal Reservoir Technology –
  • Sustained elution up to 2-3 months
  • Drug releasing Abluminal reservoirs
  • Stent material: L605 Cobalt Chromium alloy
  • Strut surface coating: Bio Inducer Surface – BIS
  • Strut thickness: 70 – 80μm
  • 2 radiopaque platinum markers at stent ends
  • No stent foreshortening during expansion


Drug releasing formulation

  • AmphilimusTM formulation: Sirolimus + Fatty Acid


Device specifications

  • Guiding catheter compatibility: 5F (0.058”)
  • Guidewire compatibility: 0.014”
  • Nominal Pressure (NP): 9 ATM
  • Rated Burst Pressure (RBP): 18 ATM
  • Average Burst Pressure (ABP): 24 ATM